Results 291 to 300 of about 583,827 (328)

Finerenone: Extending MRAs Prognostic Benefit to the Recently Hospitalized and More Symptomatic Patient with HFpEF. [PDF]

J Clin Med
Tinti MD, De Gennaro L, Limonta R, De Maria R, Carigi S, Bianco M, Di Nora C, Manca P, Matassini MV, Rizzello V, D'Elia E, Benvenuto M, Cittar M, Halasz G, Iacoviello M, Gabrielli D, Colivicchi F, Bilato C, Nardi F, Grimaldi M, Oliva F.   +20 more
europepmc   +1 more source

Digital Tinnitus Counseling in Clinical Practice: A Multicenter Randomized Controlled Trial. [PDF]

Audiol Res
Brueggemann P, Supp GG, Schmidt P, Mazurek B.   +3 more
europepmc   +1 more source

Capturing durable benefits: interpreting six-year treatment-free survival and restricted mean survival time in CheckMate 227. [PDF]

J Thorac Dis
Kobayashi T, Nakamura S, Hakozaki T.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Endpoint adjudication in cardiovascular clinical trials

European Heart Journal, 2023
Abstract Endpoint adjudication (EA) is a common feature of contemporary randomized controlled trials (RCTs) in cardiovascular medicine. Endpoint adjudication refers to a process wherein a group of expert reviewers, known as the clinical endpoint committee (CEC), verify potential endpoints identified by site investigators. Events that are
Muhammad Shahzeb Khan, Muhammad Shariq Usman, Harriette G C Van Spall, Stephen J Greene, Omar Baqal, Gary Michael Felker, Deepak L Bhatt, James L Januzzi, Javed Butler   +8 more
openaire   +2 more sources

Economic endpoints in clinical trials

Statistical Methods in Medical Research, 2004
Healthcare decision makers are increasingly requesting information on the cost and cost-effectiveness of new medicines at the time of product launch. In order to provide this information, data on healthcare resource utilization and, in some cases, costs, may be collected in clinical trials.
Cook, John, Drummond, Michael, Heyse, Joseph F.   +2 more
openaire   +2 more sources

Composite Endpoints in Clinical Trials

Revista Española de Cardiología (English Edition), 2008
Composite endpoints are often used in clinical trials, especially in the cardiovascular area. Decreases in sample size requirements, ability to assess the net effect of an intervention and to avoid bias in presence of competing risk are the most cited advantages for their use.
Ignacio, Ferreira-González, Pablo, Alonso-Coello, Ivan, Solà, Valeria, Pacheco-Huergo, Antònia, Domingo-Salvany, Jordi, Alonso, Víctor, Montori, Gaietà, Permanyer-Miralda   +7 more
openaire   +2 more sources